Research Article
Colorectal Cancer Survival is not Affected by Delay in Diagnosis
Christopher J Young2*, Raphael Varghese1, Jacqueline H Stephens1 and Andrew Hunter1
1Department ofColorectal Surgery, Royal Adelaide Hospital, Australia
2Department of Colorectal Surgery, Royal Prince Alfred Hospital, Australia
*Corresponding author: Christopher J. Young, Department of Colorectal Surgery, RPAH Medical Centre, Suite 415/100 Carillon Avenue, Newtown, New South Wales, 2042, Australia
Published: 07 Dec, 2016
Cite this article as: Young CJ, Varghese R, Stephens JH,
Hunter A. Colorectal Cancer Survival is
not Affected by Delay in Diagnosis. Clin
Surg. 2016; 1: 1238.
Abstract
Introduction: We previously published that patients were significantly less likely to have Australian clinicopathological stage (ACPS) ‘A’ colorectal cancer (CRC) tumours if there had been delayed diagnosis or if they were male. The aim of this study was to evaluate in the same group of patients the effects of delayed diagnosis, gender, age, tumour site and stage on long term survival.
Methods: All 100 patients from the 1995 study were followed up until death or between October 2000 and December 2000. Cancer specific survival (CSS) and overall survival (OS) curves were calculated by Kaplan-Meier method and compared by the log-rank test. Multivariate analysis was performed by Cox proportional hazards model.
Results: The entire cohort’s 5-year CSS was 51% and OS was 44%. Survival was significantly better for stage A tumours (CSS and OS p< 0.001) and for right sided CRC tumours (CSS p=0.026, OS p=0.037). Delayed diagnosis, gender and age were not significantly associated with survival (CSS or OS). Tumour site and stage remained significant independent prognostic indicators of survival on multivariate analysis.
Conclusions: Delay in diagnosis of symptomatic CRC does not have an effect on long-term cancer
specific or overall survival. This does not detract from the importance of early diagnosis in clinical
practice but reinforces the role of tumour site and stage in survival of CRC.
Keywords: Colorectal cancer; Delayed diagnosis; Survival
Introduction
Colorectal cancer (CRC) is the most common cancer reported to the Australian cancer registries
and is the second leading cause of cancer death after lung cancer in 2001 [1]. The lifetime risk of
colorectal cancer before the age of 75 is about one in 17 for males and one in 26 for females with
incidence increasing progressively with age [1].
Most will agree that the earlier the stage at diagnosis the higher the chance of survival from
CRC. Hospital registries from teaching hospitals in South Australia show that five year CRC survival
rates varies with the Australian Clinicopathological Stage (ACPS) [2] and is similar to the results
published elsewhere [3,4]. There is evidence from population based randomised controlled trials
that faecal occult blood screening tests reduce overall mortality from CRC [5-7]. It is logical to
assume that improved survival and reduction in mortality from CRC could be achieved by earlier
diagnosis given that only 15% of CRC in South Australia were diagnosed at ACPS stage A (confined
to the muscularis propria) [2]. Delay in seeking care has been proposed as a major reason for
significantly lower survival from CRC in lower socio-economic groups [8].
We previously demonstrated that patients were less likely to have a stage A CRC if there was
a delay in diagnosis or if they were males [9]. The aim of this study was to evaluate the effects of
delayed diagnosis, gender, age, tumour site and stage on long term survival in the same group of
patients from the 1995 study.
Methods
All 100 patients from the original study who were symptomatic patients with invasive adenocarcinoma that underwent excision of their tumours were followed up between October 2000
and December 2000 [9]. These patients had their resections for CRC at the Royal Adelaide Hospital
colorectal unit between December 1994 and November 1995. Data were collected by the clinical
research manager of the colorectal unit or by one of the authors (CJY)
from the clinical records, General Practitioners notes or from the
death registry. Patients or their relatives were interviewed in some
cases. The variables recorded for analysis include date of death or last
follow up, months to death or last follow up and cause of death, along
with the others mentioned in our original study [9].
From the original study, delay was defined to have occurred if
more than a three month period had lapsed from the time when
initial symptoms were clearly established and the time of operation
[9]. This occurred in 34 of 100 patients (34%) with the remaining 66
patients had no delay. In keeping with the original study, we further
analysed tumour stage comparing patients with Stage A tumours with
a combined Stages B, C and D group, and further analysed tumour
site comparing right sided tumours (caecum to transverse colon) with
a combined left sided (splenic flexure to sigmoid) and rectum group.
Survival curves were generated by the Kaplan-Meier method, and
the log rank test was utilised to compare survival curves. Multivariate
analysis was performed by the Cox proportional hazard regression
model. A value of p< 0.05 was considered statistically significant. 95%
confidence interval (95%CI) was calculated for variables including
gender, age, and delay in diagnosis, tumour site and stage. All
statistical analyses were performed using IBM-SPSS version 24 (IBM
Corp).
Table 1
Table 1
Univariate association between independent variables and colorectal cancer-specific survival (CSS) and overall survival (OS).
Figure 1
Figure 2
Results
All patients from the original study were followed up until death
or between October 2000 and December 2000. This includes 15
patients who had an emergency bowel resection (5 in the delay group
and 10 in the no-delay group). Twenty-one patients had a stoma as
part of their operation. The entire 100 patient cohort’s 5-year CSS was
51% and OS was 44%.
Univariate analyses with the 5-year CSS and OS rates and mean
survival times are shown in Table 1. Survival was significantly better
for stage A tumours (CSS and OS p< 0.001) and for right sided
CRC tumours (CSS p=0.026, OS p=0.037). Gender, age and delayed
diagnosis status were not significantly associated with survival (CSS or
OS). Survival curves, using the Kaplan-Meier method, are presented
in figures 1-4 for the significant variables of tumour site and stage.
In the Cox proportional hazards model (Table 2), variables
including age and delay status were rejected from the model. Tumour
site and stage remained significant independent prognostic indicators
of survival (CSS and OS) on multivariate analysis.
Figure 3
Figure 4
Discussion
Our original study looked at the prevalence and reasons for delay
in diagnosis of symptomatic CRC and the effects of delay, gender,
and age and tumour site on the stage of the disease at presentation
and demonstrated that only the gender of the patient had a significant
effect on tumour stage [9]. The present study evaluates the effects of
delay in diagnosis, gender, age and tumour site and stage on 5 year
survival in the same group of patients.
We did not find any difference in the 5 year survival rates between
patients who had diagnosis and surgery of symptomatic CRC within
3 months of onset of symptoms and patients who had a delay in
diagnosis of more than 3 months. Fifteen of the 34 patients in the delay
group had a delay of more than 9 months. The relationship between
duration of symptoms and survival in CRC has been previously
reported. Many authors agree with our observation that symptom
duration is not related to survival [10-14], whereas others believe
that prolonged duration of symptoms is associated with advanced
stage of tumour and poor survival [15,16]. Given that there is good
evidence that screening reduces mortality from asymptomatic CRC
[5-7] it may be possible that prognosis of CRC is already determined
when symptoms are present as suggested by this study. Rupasarra and
colleagues even reported improved survival for patients with delayed
diagnosis of symptomatic CRC [17], while the review of Ramos et
al. [18] reported 26 studies with no association between delay and
survival, four had better prognosis, and two had poorer prognosis.
It is well recognised that CRC survival is directly related to the
stage of the disease [2-4] and hence it was not surprising that we
found a significant 5 year survival benefit in ACPS stage A patients
compared with stage B, C and D. The entire cohorts 5-year CSS was
51% and OS was 44%, and twenty of the 55 patients who died during
the course of the study died of inter current disease.
In the present study tumours proximal to splenic flexure had
a significantly better prognosis than distal tumours. The effect of
tumour site on survival remains unclear. Right colon cancer was found
to have favourable prognosis by Halvorsen et al. [19] and Wolmark
et al. [20] whereas others noted better prognosis for sigmoid colon
tumours [21]. Kune et al. [22] confirmed better survival in right colon
cancer in multifactorial analysis. Gervaz et al. [23] in their recent
paper conclude that tumours arising from the proximal colon have
a better prognosis due to high percentage of MSI positive lesions.
Diez et al. [24] demonstrated that p53 over expression, which was
associated with lower disease free survival was more frequent in distal
than in proximal tumours.
The relationship between gender and outcome following surgery
for CRC remains controversial. We did not observe any significant
difference in survival between men and women even though there
was a trend towards better overall survival in women. Coleman et
al. [25] reported a 1-2 % survival advantage in women with rectal
cancer but found no difference in survival at 5 years between genders
in colonic cancer. However Ratto et al. [26] in his review of 18
studies found only four where gender appeared to have a significant
effect on outcome. Wichmann et al. [27] noticed significantly
longer disease free survival and overall survival in women following
curative resection of rectal cancer but found no difference in colon
cancer. McArdle et al. [28] reported a significant improvement in
overall 5 year survival in women in both colon and rectal cancer but
interestingly the cancer specific 5 year survival advantage was greater
in women who had colonic resection than rectal tumours. We did
not analyse the survival of colon and rectal cancer separately in men
and women due to the relative small number of patients involved in
the study. The small sample size is a weakness overall of this study.
Strength is the 100% follow-up of all the patients involved.
We elected to compare the survival of patients under the age of
70 years with older patients as the mean age of patients in our group
was 70.4 and we had only 8 patients under the age of 50 years. We did
not observe any significant difference in 5 year survival between the 2
groups (43 patients < 70 years; 57 patients ≥70 years). Some argue that
young age is associated with poor prognosis [29,30] yet others believe
that 5 year survival is better in younger patients [31,32]. Five of our 8
patients under the age of 50 years had advanced disease (ACPS stage
C or D).
Table 2
Table 2
Multivariate analysis of prognostic factors influencing colorectal cancer-specific survival (CSS) and overall survival (OS).
Conclusion
Delay in diagnosis of more than 3 months from onset of clearly established symptoms does not have an effect on long term cancer specific survival or overall survival for patients undergoing resection for symptomatic CRC. Site of the tumour and stage of the disease at presentation are the most significant independent prognostic factors.
References
- Australian Institute of Health and Welfare, Australian Association of Cancer Registries. Cancer in Australia 2001. Canberra: Australian Institute of Health and Welfare. 2001.
- South Australian Cancer Registry. Incidence and mortality. Epidemiology of cancer in South Australia. Incidence, mortality and survival 1977 to 1996: Open book Publishers. 1997.
- National Cancer Institute. SEER cancer statistics review, 1973-1991: tables and graphs. National Institute of Health Publications. 1994.
- Coeburgh JWW, Van der Heigden LH, Janssen-Heijnen MLG. Cancer incidence and survival in the southeast of the Netherlands, 1955-1994. Eindhoven: IKZ. 1995.
- Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reduced mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med. 1993; 328: 1365-1371.
- Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
- Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996: 1467-1471.
- Kogevinas M, Marmot MG, Fox AJ, Goldblatt PO. Socioeconomic differences in cancer survival. J Epidemiol Community Health. 1991; 45: 16-219.
- Young CJ, Sweeney JL, Hunter A. Implications of delayed diagnosis in colorectal cancer. Aust NZ J Surg. 2000; 70: 635-638.
- Holliday HW, Hardcastle JD. Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet. 1979; 1: 309-311.
- Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg. 1985; 72: 698-702.
- Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J, Lorenzo-Rocha N, Medina-Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg. 2004; 28: 716-720.
- Bharucha S, Hughes S, Kenyon V, Anderson ID, Carlson GL, Scott NA, et al. Targets and elective colorectal cancer: outcome and symptom delay at surgical resection. Colorectal Dis. 2s005; 7: 169-171.
- Roncoroni L, Pietra N, Violi V, Sarli L, Choua O, Peracchia A, et al. Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Onc. 1999; 25: 173-178.
- Robinson E, Mohilever J, Zidan J, Sapir D. Colorectal cancer: Incidence, delay in diagnosis and stage of disease. Eur J Cancer Clin Oncol. 1986; 22: 157-161.
- Lagenbach MR, Schmidt J, Neumann J, Zirngibl H. Delay in treatment of colorectal cancer: Multifactorial problem. World J Surg. 2003; 27: 304-308
- Rupassara KS, Ponnusamy S, Withanage N, Milewski PJ. A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis. 2006; 8: 423-429..
- Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguiló A, et al. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007; 43: 2467-2678.
- Halvorsen TB, Seim E. Tumour site: A prognostic factor in colorectal cancer? A multivariate analysis. Scand J Gastroenterol. 1986; 22: 124-128.
- Wolmark N, Wieand HS, Rockette HE, Fisher B, Glass A, Lawrence W, et al. The prognostic significance of tumour location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg. 1983; 198: 743-752.
- Stewart RJ, Robson RA, Stewart AW, Stewart JM, MacBeth WAAG. Cancer of the large bowel in a defined population: Canterbury, New Zealand 1970- 4. Br J Surg. 1979; 66: 309-314.
- Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R, et al. Survival in patients with large bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum. 1990; 33: 938-946.
- Gervaz P, Bucher P, Morel P. Two colons – two cancers: paradigm shift and clinical implication. J Surg Oncol. 2004; 88: 261-266.
- Diez M, Medrano M, Mugüerza JM, Ramos P, Hernandez P, Villeta R, et al. Influence of tumour localization on the prognostic value of p53 protein in colorectal adenocarcinomas. Anticancer Res. 2000; 20: 3907-3912.
- Coleman MP, Babb P, Damiecki P. Cancer survival trends in England and Wales, 1971-1995: Deprivation and NHS Region. The Stationary Office. London. 1999.
- Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GB, Crucitti F, et al. Prognostic factor in CRC. Literature review for clinical application. Dis Colon Rectum. 1998; 41: 1033-1049.
- Wichmann MW, Müller C, Hornung HM, Lau-Werner U, Schildberg FW; Colorectal Cancer Study Group. Gender differences on long term survival of patients with colorectal cancer. Br J Surg. 2001; 88: 1092-1098.
- McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg. 2003; 90: 711-715.
- Farrington SM, McKinley AJ, Carothers AD, Cunningham C, Bubb VJ, Sharp L, et al. Evidence for an age related influence of microsatellite instability on colorectal cancer survival. Int J Cancer. 2002; 98: 844-850.
- Keswani SG, Boyle MJ, Maxwell JP 4th, Mains L, Wilks SM, Hunt JP, et al. Colorectal cancer in patients younger than 40 years of age. Am Surg. 2002; 68: 871-876.
- O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY, et al. Do young colon cancer patients have worse outcomes? World J Surg. 2004; 28: 558-562.
- Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, Faivre J, et al. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum. 2001; 44: 380-387.